Clinical Trials Logo

Chest Pain clinical trials

View clinical trials related to Chest Pain.

Filter by:

NCT ID: NCT05322395 Recruiting - Clinical trials for Acute Coronary Syndrome

Pragmatic Randomised Trial of the ESC 0/1 Versus 0/3 Hour Troponin Pathway

MACROS2
Start date: December 10, 2021
Phase: N/A
Study type: Interventional

The primary objective of this study is to assess the feasibility and impact of implementing the ESC 0-1 hour high sensitive troponin pathway in clinical practice and with specific reference to the 0-3 hour pathway currently in use. The principal outcome measure will be the safety of the 0-1 hour protocol (which is less established and has limited data on safety when implemented in clinical practice)

NCT ID: NCT05288361 Recruiting - Clinical trials for Endothelial Dysfunction

The DISCOVER INOCA Prospective Multi-center Registry

DISCOVER INOCA
Start date: September 14, 2022
Phase:
Study type: Observational [Patient Registry]

The overall objective of this multi-center registry is to identify specific phenotypes of INOCA with both an anatomic evaluation (coronary angiography and intravascular imaging) and physiologic assessment with the Abbott Coroventis Coroflow Cardiovascular System, and to determine long-term outcomes.

NCT ID: NCT05174247 Recruiting - Chest Pain Clinical Trials

Addition of FFRct in the Diagnostic Pathway of Patients With Stable Chest Pain

Fusion
Start date: July 27, 2021
Phase: N/A
Study type: Interventional

Rationale: Patients with stable chest pain enter a diagnostic pathway where Coronary Computed Tomography Angiography (CCTA) is often the first line non-invasive test to detect coronary stenosis. An anatomically significant (≥ 50% luminal narrowing) stenosis on CCTA does however not always cause cardiac ischemia (i.e. hemodynamically significant stenosis). CCTA is often followed by invasive coronary angiography (ICA) to assess the hemodynamic significance of the stenosis which is the key determinant to decide on treatment (revascularization by coronary stenting or surgery). CCTA has a very high negative predictive value but the positive predictive value is moderate. Hence, anatomically significant stenoses on CCTA often turn out not to be hemodynamically significant on ICA. Fractional Flow Reserve from coronary computed tomography (FFRct) analysis is a new non-invasive technique that uses the CCTA images as a basis for complex software based calculations and modelling to provide additional functional information based on the anatomical CCTA images. Thus, FFRct is a totally non-invasive method. Adding the FFRct analysis to the anatomical assessment of CCTA is expected to reduce the number of patients being referred to ICA where no signs of hemodynamically significant stenosis are found on ICA.

NCT ID: NCT04904107 Recruiting - Clinical trials for Myocardial Infarction

Improving the Accuracy of Referrals of Patients With Chest Pain

URGENT2
Start date: July 4, 2021
Phase: N/A
Study type: Interventional

This is a multicenter, prospective, investigator-initiated, randomized controlled trial aiming to reduce the percentage of non-cardiac chest pain (NCCP) patients admitted to the cardiac emergency department (ED) by performing the modified HEART score by emergency medical transport (EMT) personnel.

NCT ID: NCT04851418 Recruiting - Clinical trials for Coronary Artery Disease

Pre-hOspital Evaluation of Chest Pain Patients With sUspected Non ST-segment eLevation myocARdial Infarction Using the HEART-score With a Troponin Point-of-care Test

POPular HEART
Start date: September 1, 2020
Phase:
Study type: Observational

Overcrowding in the emergency department is an increasing problem in hospitals worldwide. Point-of-care Troponin (POC cTn) testing combined with a well investigated risk stratification tool (HEART-score) used in the ambulance may contribute to more rapidly diagnostics of ruling in or ruling out myocardial infarctions (MI) and subsequently reduce unnecessary hospital admissions, total admission time and costs. However, the applicability of the POC cTn and the HEART-score in the pre-hospital setting remains unclear. This study will evaluate this applicability.

NCT ID: NCT04748237 Recruiting - Clinical trials for Coronary Artery Disease

Coronary Computed Tomographic Angiography in Intermediate-risk Chest Pain Patients

FAST-CCTA
Start date: January 21, 2021
Phase: N/A
Study type: Interventional

The aim is to determine whether a diagnostic strategy including early coronary computed tomographic angiography in intermediate-risk patients presenting to the Emergency Department with chest pain reduces the composite endpoint of death, readmission because of myocardial infarction or unstable angina requiring revascularization.

NCT ID: NCT04716816 Recruiting - Chest Pain Clinical Trials

Stripping Massage After Thoracoscopy

SMAT
Start date: January 17, 2021
Phase: N/A
Study type: Interventional

This study investigated the effects of stripping massage (SM) on myofascial trigger points in the rhomboid after thoracoscopic surgery.

NCT ID: NCT04709900 Recruiting - Stroke Clinical Trials

CT Stress Myocardial Perfusion, Fractional Flow Reserve and Angiography in Patients With Stable Chest Pain Syndromes

DYNAMITE
Start date: December 3, 2021
Phase: N/A
Study type: Interventional

The purpose of the DYNAMITE trial (Dynamic CT stress myocardial perfusion, CT fractional flow reserve (FFR-CT) and coronary CT angiography for optimized treatment strategy in patients with chest pain syndromes) is to determine the ability of combined anatomical and functional cardiac CT imaging to improve morbidity and mortality in patients with suspected or known ischemic heart disease.

NCT ID: NCT04691037 Recruiting - Clinical trials for Coronary Artery Disease

CCTA Improves Clinical Management of Stable Chest Pain

CICM-SCP
Start date: January 1, 2016
Phase:
Study type: Observational [Patient Registry]

The investigator aims to prospectively enroll patients who were referred for coronary computed tomography angiography (CCTA) for the assessment of stable chest pain (SCP) suspected of obstructive coronary artery disease (CAD). All patients underwent CCTA according to established guidelines and local institutional protocols. The imaging data were evaluated using different image post-processing software to comprehensively analyse anatomical, functional and histological information of coronary. This study will determine if CCTA-based imaging evaluation can provide more informaton to improve clinical management for SCP, including fewer MACE and better decision-making of downstream investigations and therapeutic interventions.

NCT ID: NCT04661722 Recruiting - Chest Pain Clinical Trials

A Comparison of the TIMI, GRACE, HEART and HEARTSIL Scores

Start date: February 5, 2021
Phase:
Study type: Observational

Chest pain is one of the most common reasons for emergency admission. Chest pain can be caused by many cardiac and noncardiac causes. Acute Coronary Syndrome (ACS) is one of the most im-portant of these etiologies. ACS has a high mortality rate, but with early diagnosis and related inter-ventions, a high rate of prognosis can be improved. Therefore, early recognition of AKS is impor-tant. However, the challenge in emergency services is not only to identify patients with high risk for ACS. Early detection of low-risk patients is also important for emergency room management. These patients should be discharged quickly with minimal examination and treatment. The follow-up of these patients with the acceptance of ACS brings along unnecessary examinations and treatments. This leads to an increase in healthcare costs and an increase in crowd in emergency services and hospitals. Evaluation of chest pain in the emergency room and early detection of life-threatening conditions such as ACS present many difficulties for clinicians. For this reason, clinicians use some scoring systems that determine the risk stratification of patients and the probability of having acute coronary syndrome. Heart score is one of the scores developed for this purpose. However vital signs are not included in calculating the heart score. Therefore, the investigators considered to include the shock index calcula-ted by systolic blood pressure and pulse in this scoring system. In addition, the investigators have included a very valuable biochemical parameter such as lactate that predicts mortality in many diseases in this scoring system. The investigators named this scoring system HEARTSIL. The investigators aim to compare the diagnostic performance of this score with the diagnostic performance of other scoring systems.